In breast cancer, estrogen induces FOSL2/Wnt5a expression via cAMP/PKA signaling, in turn, the secreted Wnt5a regulates FZD5/NK-kB/ERK signaling in vascular endothelial cells to promote tumor angiogenesis [234]. Here, WNT5A is linked to breast cancer.